CeraShield Endotracheal Tube
Prevention of Ventilator-Associated Pneumonia (VAP)
Pre-market ApprovalActive
Key Facts
Indication
Prevention of Ventilator-Associated Pneumonia (VAP)
Phase
Pre-market Approval
Status
Active
Company
About N8 Medical
N8 Medical is a private, clinical-stage company developing antimicrobial coatings for medical devices to combat HAIs and antimicrobial resistance (AMR). Its lead CeraShield-coated endotracheal tube has received FDA Breakthrough Device designation and is cleared for use in several ex-US markets, with FDA approval anticipated. The company leverages significant non-dilutive funding through NIH SBIR grants and is structured under a holding company, N8 Biosciences, with a therapeutic drug development subsidiary, Kinnear Pharmaceuticals.
View full company profileTherapeutic Areas
Other Prevention of Ventilator-Associated Pneumonia (VAP) Drugs
| Drug | Company | Phase |
|---|---|---|
| PhotoDisinfection for Endotracheal Tubes | LightLine Medical | Development |